This is a video episode, catch the video on Nelson John 360 Youtube Channel

A small Bangalore jewellery shop became a Fortune 500 gold giant, then SEBI alleged that nearly ₹15 lakh crore of its revenue couldn't be verified. This episode breaks down the full Rajesh Exports story: the missing money, the broker who says the trades never happened, the fund routing, the African mine, and the Telangana factory that never got built and why it matters to ordinary investors, including LIC.

Note: SEBI's order is interim; these are allegations, not proven findings. The company denies wrongdoing. For information only, not investment advice.

For years, pancreatic cancer offered patients very little. A new drug could be changing that, nearly doubling how long patients live. But is it a cure, and who can actually get it? Today, Nelson breaks it down for you in plain, easy to understand language, no medical jargon needed.

This week, in three days of negotiations in New Delhi, India and the United States are finalising the first tranche of their Bilateral Trade Agreement the most consequential trade pact between the two nations in over a decade. In this episode of Nelson John 360, we walk through the full story: from the Liberation Day tariffs of April 2025 to the 50 percent combined duty of August, the February 2026 framework that brought it down to 18 percent, and the three-day window that began on June 2, 2026 to formalise the deal.

We cover what is in the agreement, what India has agreed to in exchange, the contested DDGS and GM crops question, who in Indian industry gains, and what the second tranche will likely look like. Grounded in verified data from the Ministry of Commerce, the US Trade Representative, the Indian Pharmaceutical Alliance, and the Reserve Bank of India.